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Abstract 
OBJECTIVE: 
To compare anxiety and/or depressive symptoms between patients with end-stage renal 
disease with and without comorbid diabetes and identify factors associated with symptoms of 
distress in this population  
METHODS: 
Data from two studies (conducted between 2010 - 2014) were pooled. A total of 526 patients 
on hemodialysis (68.8% with diabetes) completed the Hospital Anxiety and Depression Scale 
(HADS). Elevated symptoms were defined as HADS-Anxiety or HADS-Depression ≥8. 
Univariate and multivariate logistic regressions were used to estimate associations between 
diabetic status, and other socio-demographic and clinical factors with baseline clinical 
anxiety and depression. 
RESULTS: 
A total of 233 (45.4%) reported elevated anxiety symptoms and 256 (49.9%) reported 
elevated depressive symptoms sufficient for caseness.  Rates were not different between 
patients with and without diabetes. Risk for clinical depression was higher in patients who 
were single/unpartnered (OR = 1.828), Chinese vs. Malay (OR = 2.05), or had lower albumin 
levels (OR = 0.932). None of the parameters were associated with anxiety caseness. 
CONCLUSION: 
Sociocultural factors rather than comorbid burden may help identify patients at risk for 
depression. The high rates of anxiety and depression underlie the importance for monitoring 
and intervention in dialysis care.   
 
 Keywords: Anxiety, Depression, Diabetes mellitus, End-stage renal disease  
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Prevalence and determinants of Anxiety and Depression in End Stage Renal Disease (ESRD). 
A comparison between ESRD patients with and without coexisting Diabetes Mellitus 
Emotional distress, as indexed by symptoms of anxiety and depression, is common in 
chronic illness.  Incidence/prevalence rates and severity of symptoms are markedly higher in 
patients with long term conditions, e.g. diabetes mellitus (DM) [1], heart disease [2], 
rheumatoid arthritis [3] or chronic kidney disease [4], compared to the general population.  
While exact estimates may vary due to methodological/measurement differences across 
studies, there is overwhelming evidence that chronic illness with comorbid depression is 
associated with increased symptom burden and functional impairment, poor quality of life, 
non-adherence to treatment, and worse clinical outcomes [5,6].  
Multimorbidity, the co-occurrence of two or more physical conditions that require 
active management, can intensify treatment demands and psychological impact over and 
beyond that of individual conditions [7]. In particular, end-stage renal disease (ESRD) with 
comorbid diabetes has emerged as a new challenge for health services. Over 50% of dialysis 
patients receive renal replacement therapy due to diabetic nephropathy [8,9]. They represent 
the fastest growing and most ‘frail’ patient segment in renal care worldwide. The greater 
comorbid burden and treatment demands/complexity for DM ESRD patients [10] could 
aggravate symptoms of distress [11] and hinder emotional adjustment. Yet, while DM ESRD 
patients are known to have poorer prognoses, little is known on the psychological status of 
this group relative to general ESRD population [12]. There is clear need to evaluate these 
outcomes to develop efforts to provide better care.  
 The present study aimed to document and compare prevalence rates of anxiety and 
depression between ESRD patients with and without coexisting DM, hypothesizing that DM 
patients would experience greater psychological distress given greater comorbid burden, as 
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well as identify other socio-demographic and clinical factors associated with anxiety and 
depression in the ESRD population. 
 
Methods 
Data used were pooled from two studies, conducted between 2009 [13] and 2014 [14] 
in National Kidney Foundation (NKF), Singapore. These included baseline data (collected 
prior randomization) from the HED-SMART trial, a pragmatic RCT (Trial Registration: 
ISRTN31434033) to evaluate the effectiveness of self-management intervention  to improve 
clinical and patient reported outcomes in hemodialysis patients (13) and data from a Phase I 
study  (CDIRECT – Combined Diabetes and Renal Control Trial) undertaken to examine 
needs of patients with coexisting diabetes (either Type 1 or Type 2) and ESRD so as to 
develop a specific program of support [14]. Study protocols were in compliance with the 
Helinski declaration and were approved by the NUS Institutional Review Board. Eligible 
participants were recruited from the general pool of patients in the dialysis centres by 
research personnel independent to their renal care team. Inclusion criteria for both studies 
were: (i) age ≥21 years, (ii) on hemodialysis for a minimum of 3 months, (iii) able to 
understand English and/or Mandarin or Malay, and (iv) free of cognitive, major visual or 
auditory impairments and life-limiting condition diagnosis (e.g. terminal cancer) as recorded 
in medical notes and verified by nurse manager in participating dialysis centres. Informed 
consent was obtained from all study participants. 
Measures 
Demographic information included gender, age, ethnicity, education, employment, 
marital/relationship status, monthly household income, living arrangement, and housing. 
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Medical records were reviewed to extract information on primary kidney diagnosis, months 
on dialysis, and measures of potassium, phosphate, haemoglobin, albumin and Kt/V. 
Comorbidity burden was assessed using the Charlson Comorbidity Index (CCI) [15]. 
The 14-item self-report Hospital Anxiety and Depression Scale (HADS) [16] was 
used to measure depressive and anxious symptoms (7 items each). Items are rated on a 4-
point scale (0 to 3), with larger scores indicating greater severity of symptoms. The scale is 
widely used across patient populations and has been found to display reasonable sensitivity 
and specificity when caseness is defined by a score of 8 or higher for each subscale [17]. 
Either the English or Mandarin validated versions were used (as appropriate).  
Statistical analyses 
All statistical analyses were performed using SPSS V20. Continuous variables were 
expressed as means and standard deviations. Categorical variables were expressed as absolute 
values and percentages. Differences between ESRD subgroups in continuous variables were 
tested using independent sample t-tests, and differences in categorical variables were assessed 
using Pearson’s χ2 test. HADS-A and HADS-D scores were calculated and coded for 
caseness using the cut-off score of 8.  
Univariate logistic regressions were conducted to investigate factors associated with 
anxiety and depression caseness. All parameters significant at univariate analyses were 
subsequently modelled in a multiple regression model. Percentage of variance explained was 
determined using Cox and Snell’s R2. 
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Results 
The sample comprised 526 hemodialysis participants (Mean age: 56.1±10.8; 41.3% 
female; 53.8% Chinese) (Table I). Of these, 363 (68.8%) had diabetes, while the remaining 
161 (30.9%) did not. Medical information was missing for the remaining 2 participants 
(0.3%).  Mean HADS-A score (7.29±4.17) and HADS-D scores (7.82±4.24) were below the 
cut-off, hence considered to be in ‘normal’ range.  Prevalence of caseness for anxiety and 
depression based on the cut-off was 45.2% and 50.4% respectively. 
Significant casemix differences between DM ESRD and non-DM ESRD were noted 
on several socio-demographic parameters (Table I). Patients with DM ESRD were older, had 
lower education and employment rates and were less likely to be home owners or Chinese. 
They had been on dialysis for a shorter time (p<.001), had higher CCI scores (p<.001), higher 
albumin (p=.008) and lower haemoglobin levels (p<.001) compared to non-DM ESRD 
counterparts.  
Comparisons indicated that depression levels were equivalent between DM ESRD 
(7.88±4.37) and non-DM ESRD patients (7.64±3.88). Anxiety levels were significantly 
higher in DM ESRD (7.66±4.09) relative to non-DM ESRD (6.41±4.18) (p =.001), though 
mean scores were still within normal ranges. Rates of anxiety (47.4% vs. 40.4%, p=.137) and 
depression (49.9% vs. 51.6%, p=.721) caseness were similar between DM ESRD vs. non-
DM ESRD patients respectively. These effects persisted even after comparisons were 
adjusted for casemix differences, i.e. severity of symptoms of depression and rates of 
caseness for anxiety and depression remained equivalent across groups.   
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Table I 
Summary comparison of demographic variables and clinical parameters  
 Total Non-DM  DM  
 M ± SD/N (%) M ± SD/N (%)  M ± SD/N (%) p 
Total 526 161 (31)  363 (69) - 
HADS-Anxiety  7.28±4.153 6.41±4.184  7.66±4.086 .001** 
Anxiety caseness (HADS≥8) 233 (45.4) 65 (40.4)  172 (47.4) .137 
HADS-Depression 7.81±4.225 7.64±3.879  7.88±4.373 .547 
Depression caseness (HADS≥8) 256 (49.9) 83 (51.6)  181 (49.9) .721 
 
Socio-demographic variables  
     
Gender     .306 
 Male  309 (59) 89 (55)  218 (60)  
 Female  217 (41) 72 (45)  145 (40)  
Age 56.10±10.84 51.45±11.84  58.10±9.67 <.001*** 
Ethnicity     .043* 
 Chinese 272 (53) 99 (62)  182 (50)  
 Malay 185 (36) 48 (30)  138 (38)  
 Others 55 (11) 13 (8)  43 (12)  
Relationship status     .340 
 With partner 340 (65) 109 (68)  231 (64)  
 Without partner  184 (35) 51 (32)  131 (36)  
Highest Qualification Level     .003** 
 Primary and below  209 (40) 51 (32)  157 (44)  
 Secondary  232 (45) 73 (46)  159 (44)  
 Tertiary 80 (15) 36 (22)  43 (12)  
Employment status     <.001*** 
 Employed/Student  143 (28) 72 (46)  71 (20)  
 Unemployed 126 (24) 29 (19)  97 (27)  
 Retired 98 (19) 17 (11)  80 (22)  
 Looking after home and family 78 (15) 24 (15)  54 (15)  
 Others 75 (14) 16 (10)  59 (16)  
Monthly Household Income     .716 
 $0 - $2000  257 (49) 81 (51)  174 (48)  
 $2001 - $4000  123 (24) 34 (22)  89 (25)  
 $4001 - $6000  23 (5) 9 (6)  14 (4)  
 $6001 and above  18 (3) 7 (4)  11 (3)  
 Don’t know 74 (14) 19 (12)  54 (15)  
 Do not wish to answer 27 (5) 8 (5)  19 (5)  
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Living Arrangement     <.001*** 
 Home owner 206 (39) 84 (53)  122 (34)  
 Renting 202 (39) 24 (15)  177 (49)  
 Others  115 (22) 50 (32)  64 (17)  
Housing      .225 
 1-2 room public housing 59 (11) 13 (8)  45 (12)  
 3-4 room public housing  370 (71) 121 (76)  247 (69)  
 5 room public housing and above 92 (18) 26 (16)  68 (19)  
      
Clinical Parameters      
Primary Kidney Diagnosis     <.001*** 
 Diabetes 309 (63) 0 (0)  310 (89)  
 Hypertension 25 (5) 18 (13)  7 (2)  
 Glomerulonephritis 93 (19) 74 (51)  20 (6)  
 Others 62 (13) 52 (36)  11 (3)  
Time on Dialysis (months) 52.9±53.2 75.4±63.4  43.0±44.6 <.001*** 
Charlson Comorbidity Index 6.78±3.00 3.75±1.68  8.09±2.44 <.001*** 
Potassium (mmol/l) 4.70±0.65 4.75±0.65  4.68±0.66 .314 
Phosphate (mmol/l) 5.01±2.74 5.49±3.44  4.80±2.35 .009** 
Haemoglobin (g/dl) 11.02±1.54 11.51±1.39  10.81±1.56 <.001*** 
Albumin (g/dl) 35.55±3.69 34.96±3.11  35.82±3.87 .016** 
Kt/V 1.57±0.42 1.61±0.29  1.55±0.47 .122 
* p < .05, **p < .01, ***p<.001 
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Factors associated with anxiety and depression prevalence 
Increased prevalence of anxiety not associated with any variable (Table II) hence 
multivariate analysis was not performed. 
For depression, univariate analyses revealed that increased prevalence was associated 
with higher phosphate levels (OR=1.132, p=.050) and lower albumin levels (OR=0.944, 
p=.021), and strongly associated with being single, widowed or divorced (OR=1.858, 
p=.001). Chinese also reported significantly higher rates of depression compared to both 
Malay (OR=1.748, p=.003) and “Other” ethnicities (OR=1.894, p=.032). 
The multiple regression model including ethnicity, relationship status, phosphate and 
albumin levels explained 6.1% of the variance. The results also indicate that increased 
prevalence of depression is independently associated with being single, widowed or divorced 
(OR=1.827, p=.002), being Chinese vs. Malay (OR=2.05, p=.004) and lower albumin levels 
(OR=0.932, p=.006).  
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Table II 
Univariate and multivariate logistic regressions for anxiety and depression caseness (n = 526) 
 
Variables 
 
Anxiety   Depression  
Univariate    Univariate  Multivariate 
 OR 95% CI p R2  OR 95% CI p R2 OR 95% CI p 
Diabetes (yes) 1.330 0.913-1.938 .137 .004  0.935 0.645-1.355 .721 .000    
Gender (female) 1.408 0.993-1.997 .055 .007  1.122 0.793-1.588 .515 .001    
Age (years) 0.999 0.983-1.015 .859 .000  1.002 0.986-1.018 .814 .000    
Ethnicity   (Chinese)  1.000 - - .002  1.000 - - .018 1.000 - - 
                  (Malay) 0.942 0.650-1.366 .753   0.572 0.394-0.831 .003**  0.567 0.384-0.837 .004** 
                  (Others) 0.686 0.381-1.237 .211   0.528 0.295-0.945 .032*  0.568 0.305-1.055 .073 
Relationship status (without partner)  1.257 0.877-1.802 .213 .003  1.858 1.291-2.676 .001** .021 1.827 1.245-2.682 .002** 
Highest Qualification (Primary and below) 1.000 - - .000  1.000 - - .000    
                                    (Secondary) 1.152 0.791-1.678 .462   0.890 0.612-1.293 .540     
                                    (Tertiary) 1.082 0.644-1.817 .766   1.002 0.598-1.678 .993     
Employment  (No formal employment) a 1.364 0.923-2.017 .120 .005  1.327 0.902-1.953 .151 .004    
Monthly Household Income b (<$2000) 1.106 0.747-1.639 .614 .002  1.308 0.883-1.937 .180 .004    
Living Arrangement (home owner) 0.869 0.610-1.236 .434 .002  1.198 0.843-1.702 .314 .000    
Housing (1-2 room public housing) 1.000 - - .020  1.000 - - .000    
               (3-4 room public housing) 0.918 0.530-1.591 .761   1.128 0.651-1.954 .668     
               (5 room public housing and above) 0.577 0.298-1.116 .102   0.820 0.427-1.573 .550     
Time on Dialysis (months) 0.998 0.995-1.002 .362 .002  1.000 0.997-1.004 .864 .000    
Charlson Comorbidity Index 1.028 0.970-1.089 .355 .002  0.985 0.930-1.044 .608 .001    
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Potassium (mmol/l) 0.804 0.613-1.055 .115 .005  0.939 0.719-1.226 .643 .000    
Phosphate (mmol/l) 1.030 0.962-1.104 .396 .002  1.132 1.000-1.281 .050* .012 1.129 0.991-1.286 .067 
Haemoglobin (g/dl) 1.002 0.894-1.123 .976 .000  1.061 0.946-1.189 .313 .002    
Albumin (g/dl) 0.966 0.921-1.013 .156 .004  0.944 0.899-0.991 .021* .011 0.932 0.887-0.980 .006** 
Kt/V 1.172 0.766-1.793 .465 .001  1.043 0.689-1.579 .843 .000    
* p < .05, **p < .01 
OR: Odds ratios; CI: Confidence intervals 
a Includes those who are retired, unemployed, or indicated ‘Others’ 
b N=27 participants ticked option ‘do not wish to answer’ and N = 71 indicated ‘don’t know’ and were excluded 
R2 for multivariate model = .061 
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Discussion 
In general, our findings showed high prevalence for both anxiety and depression in 
ESRD patients, with figures consistent with reports from other countries [18,19], calling forth 
need for screening and interventions. A number of treatment approaches have been applied to 
patients with comorbid depression and long-term conditions, including pharmacotherapy, 
non-pharmacological approaches (e.g. cognitive behavioral therapy), and health systems 
interventions (e.g. collaborative care teams). More work is needed to explore how these can 
be applied in dialysis settings. 
Contrary to our expectations, emotional adjustment outcomes were largely equivalent 
between DM ESRD and non-DM ESRD patients. Symptoms of depression were also levelled 
across groups. Only mean anxiety levels were significantly higher in DM ESRD, yet scores 
were still within normal range. Hence, the observed difference of 1 point in HADS-Anxiety 
while statistically significant is unlikely to be clinically significant. To this end, it is 
noteworthy that rates of anxiety and depression caseness, shown to prognosticate poor 
clinical outcomes [20] were comparable for DM ESRD and non-DM ESRD patients in both 
casemix-adjusted and unadjusted comparisons.  This pattern of results is striking considering 
that DM ESRD patients have substantially greater comorbid burden, which previous work 
has shown to be related to distress indicators [21]. Nonetheless, the uniform psychological 
responses indicate that parameters other than comorbid burden/disease severity may be better 
suited to identify patients more at risk for distress.  To this end, our findings underscore the 
importance of sociocultural factors.   
Consistent with previous research, we found that single/unpartnered patients were 
shown to be at increased risk for depression relative to those married /partnered. The 
observed associations between depression caseness and relationship status are likely to reflect 
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the effects of low social support [22] in unpartnered individuals. Single/unpartnered status 
may also imply limited availability of emotional, substantive and instrumental resources (e.g. 
transportation, daily assistance).  
The association with ethnicity is quite compelling, and differences in cultural beliefs 
and norms may explain the differential impact across ethnic groups. Chinese families tend to 
hold strongly to social-role obligations such that chronic conditions can be sources of 
frustration, tension and guilt. In Malay families on the other hand, the patient is more 
willingly released from such obligations [23]. Malay individuals may also possess strong 
protective factors such as increased religiosity [24] and strong informal social networks [25], 
whereas Chinese tend to rely more on self-directed coping strategies [26]. While more work 
and further replication is imperative, these findings suggest the need for providers to be 
vigilant for depression among patients with Chinese ancestry.  
The only clinical parameter associated with depression was albumin – with lower 
albumin associated with higher odds of depression. This corroborates past findings that 
depressed patients tend to exhibit poorer nutritional status [27], and thereby poorer health 
outcomes [28]. Providers may consider screening for depression among patients with reduced 
albumin levels. 
Interestingly, none of the parameters examined were associated with anxiety caseness; 
hence segmentation based on socio-demographic or clinical profile is not supported, contrary 
to previous work in non-Asian settings [29].  Factors such as illness beliefs have strong 
associations with depression [30] and may also be important in explaining symptoms of 
anxiety. Nevertheless, these findings underscore the importance of screening and monitoring 
symptoms for all renal care patients.  
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Study limitations need to be noted. First, the cross-sectional design does not allow us 
to determine causal relationships or course of distress over time. Longitudinal work is needed 
to map outcome trajectories across patient segments.  Screening for eligibility was based on 
medical history with no formal cognitive diagnostic evaluation.  Also, caseness was based on 
self-report data. While established cut-offs were used to allow comparability with previous 
work, these have yet to be validated for Mandarin and Malay versions.  Diagnostic interviews 
have greater sensitivity and specificity and should be preferred for future work [4].  
Conclusion 
 Rates of anxiety and depression are high within the ESRD population, and efforts 
should be made to monitor and alleviate such symptoms where they occur. Comorbid burden 
or diabetes was not associated with increased risk for anxiety and depression. Ethnicity, 
relationship status, and poor nutritional status were indicative of depression yet none of the 
parameters predicted anxiety caseness. The study highlights the importance of sociocultural 
factors in screening patients for depression, regardless of health status, so as to provide timely 
and appropriate care.  
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